Skip to search formSkip to main contentSkip to account menu

Lovaza

Known as: Omacor 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (5)

Docosahexaenoic AcidsDrug CombinationsEicosapentaenoic AcidOmega-3 Acid Ethyl Esters (USP)
Lovaza PillOmega-3 Acid Ethyl Esters (USP) 1000 MG Oral Capsule [Lovaza]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Obesity-associated alterations in cardiac connexin-43 and PKC signaling are attenuated by melatonin and omega-3 fatty acids in female rats
We aimed to explore whether specific high-sucrose intake in older female rats affects myocardial electrical coupling protein… 
Review
2014
Review
2014
Omacor and Omega-3 Fatty Acids for Treatment of Coronary Artery Disease and the Pleiotropic Effects
ABSTRACTOmega-3 polyunsaturated fatty acids are found in fish oil and they have been shown to mitigate the risk of cardiovascular… 
2014
2014
Omega‐3 fatty acids and/or fluvastatin in hepatitis C prior non‐responders to combination antiviral therapy – a pilot randomised clinical trial
Hepatitis C virus (HCV) utilises cholesterol and lipoprotein metabolism for replication and infectivity. Statins and omega‐3 (n–3… 
2013
2013
Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet.
Increased arterial stiffness is associated with enhanced risk of cardiovascular disease in obese individuals. Whether n3 fatty… 
2011
2011
Early Impact of Prescription Omega-3 Fatty Acids on Platelet Biomarkers in Patients with Coronary Artery Disease and Hypertriglyceridemia
Background: Prescription omega-3-acid ethyl esters (PO-3A) have been tested for outcome benefits in patients with coronary artery… 
2007
2007
Analysis of long-chain ω-3 fatty acid content in fish-oil supplements
ZusammenfassungHINTERGRUND: In zahlreichen Studien wurden die verschiedensten vorteilhaften Effekte von mehrfach ungesättigten… 
Review
2006
Review
2006
Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
Re-analysis of the North American IgA Nephropathy Study suggested that efficacy of omega-3 polyunsaturated fatty acids (omega-3… 
2006
2006
A cost‐effectiveness analysis of n‐3 PUFA (Omacor®) treatment in post‐MI patients
This study evaluates the cost‐effectiveness of omacor treatment as a standard prevention measure post‐MI in the UK. A cost… 
Review
2006
Review
2006
Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
The therapeutic options for interfering with the electrical instability of a pathologically remodeled or ischaemic heart remain… 
2005
2005
The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)